- Filed
- Mar 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 10, 2026 | 9.6M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 6.89M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 5.49M sh |
| Capex | FY 2025 · Dec 31, 2025 | $1.74M |
| Capex | FY 2025 · Dec 31, 2024 | $1.12M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$95.25M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$92.38M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $38.92M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $56.5M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $159.21M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $186.61M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $170.18M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $21.53M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $19.39M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $33.15M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $33.61M |
| Current Assets | FY 2025 · Dec 31, 2025 | $160.93M |
| Current Assets | FY 2025 · Dec 31, 2024 | $180.14M |
| Total Assets | FY 2025 · Dec 31, 2025 | $192.36M |
| Total Assets | FY 2025 · Dec 31, 2024 | $220.22M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$16.95 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$21.33 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$16.95 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$21.33 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $22.99M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $28.29M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $99.13M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $99.32M |
| Net Income | FY 2025 · Dec 31, 2025 | −$116.8M |
| Net Income | FY 2025 · Dec 31, 2024 | −$117.12M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$122.11M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$127.62M |